Pyrimidine carboxamides as sodium channel blockers
US9637458B2 · kind B2 · utility
2Cited by
25References
19Claims
0Family size
Inventors
Key dates
| Filing date | Mar 3, 2014 |
| Grant date | May 2, 2017 |
| Priority date | — |
| Expiry date | Mar 3, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides substituted pyrimidine carboxamides of Formula (I) and the pharmaceutically acceptable salts and solvates thereof, wherein A1, X, A2, W1, W2, W3, E, Z, and R4 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of sodium channels. Compounds of the present disclosure are especially useful for treating pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.